Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L McGregor

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pathophysiology of Haemostasis and Thrombosis|June 18, 2003
Current perspective on antithrombin drugsJohn L McGregor
British Journal of Haematology|February 18, 2003
A peptide (P2) derived from the variable heavy chain of an anti-P-selectin monoclonal antibody (LYP20) inhibits leucocyte adhesion to thrombin-activated platelets and endothelial cellsJoseph F Murphy, John L McGregor
Journal of Biomedicine & Biotechnology|December 19, 2002
CD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6)Kazem Zibara, Eric Malaud, John L. McGregor
Journal of Biomedicine & Biotechnology|September 30, 2005
Identification, structural, and functional characterization of a new early gene (6A3-5, 7 kb): implication in the proliferation and differentiation of smooth muscle cellsKazem Zibara, Gwenaële Garin, John L McGregor
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosisLilian McGregor, Juliette Martin, John L McGregor
Bioscience Reports|June 19, 2008
CD36 N-terminal cytoplasmic domain is not required for the internalization of oxidized low-density lipoproteinChris McDermott-Roe, Juliette Martin, Sophie Collot-Teixeira, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 22, 2007
Scavenger receptor A and CD36 are implicated in mediating platelet activation induced by oxidized low- density lipoproteinsSophie Collot-Teixeira, Ferrucio De Lorenzo, Ferrucio Delorenzo, et al.
The Biochemical Journal|May 25, 2002
The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoproteinEric Malaud, Delphine Hourton, Louise Marie Giroux, et al.
Journal of Biomedicine & Biotechnology|May 10, 2007
6A3-5/Osa2 is an early activated gene implicated in the control of vascular smooth muscle cell functionsGwenaele Garin, Kazem Zibara, Frederick Aguilar, et al.
Vascular Health and Risk Management|May 14, 2009
Prevention of atherosclerosis in patients living with HIVFerruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pathophysiology of Haemostasis and Thrombosis|June 18, 2003
Current perspective on antithrombin drugsJohn L McGregor
British Journal of Haematology|February 18, 2003
A peptide (P2) derived from the variable heavy chain of an anti-P-selectin monoclonal antibody (LYP20) inhibits leucocyte adhesion to thrombin-activated platelets and endothelial cellsJoseph F Murphy, John L McGregor
Journal of Biomedicine & Biotechnology|December 19, 2002
CD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6)Kazem Zibara, Eric Malaud, John L. McGregor
Journal of Biomedicine & Biotechnology|September 30, 2005
Identification, structural, and functional characterization of a new early gene (6A3-5, 7 kb): implication in the proliferation and differentiation of smooth muscle cellsKazem Zibara, Gwenaële Garin, John L McGregor
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosisLilian McGregor, Juliette Martin, John L McGregor
Bioscience Reports|June 19, 2008
CD36 N-terminal cytoplasmic domain is not required for the internalization of oxidized low-density lipoproteinChris McDermott-Roe, Juliette Martin, Sophie Collot-Teixeira, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 22, 2007
Scavenger receptor A and CD36 are implicated in mediating platelet activation induced by oxidized low- density lipoproteinsSophie Collot-Teixeira, Ferrucio De Lorenzo, Ferrucio Delorenzo, et al.
The Biochemical Journal|May 25, 2002
The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoproteinEric Malaud, Delphine Hourton, Louise Marie Giroux, et al.
Journal of Biomedicine & Biotechnology|May 10, 2007
6A3-5/Osa2 is an early activated gene implicated in the control of vascular smooth muscle cell functionsGwenaele Garin, Kazem Zibara, Frederick Aguilar, et al.
Vascular Health and Risk Management|May 14, 2009
Prevention of atherosclerosis in patients living with HIVFerruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, et al.
Pageof 2